Search research articles
Contact Us
Filters
Showing results (171-180 of 310) with videos related to
Page
of 31
Sort By:
Seminars in Thrombosis and Hemostasis
|
November 5, 1999
Preclinical differentiation of low molecular weight heparins
H B Nader, J M Walenga, S D Berkowitz, et al.
Drugs
|
February 1, 1991
Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications
E E Müller, V Locatelli, E Ghigo, et al.
Clinical Endocrinology
|
August 1, 1986
The effect of oxandrolone on the growth hormone response to growth hormone releasing hormone in children with constitutional growth delay
S Loche, R Corda, A Lampis, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1997
Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration
G Cella, A Cipriani, A Tommasini, et al.
Journal of Immigrant and Minority Health
|
July 28, 2016
Drugs Delivery by Charities: A Possible Epidemiologic Indicator in Children of Undocumented Migrants
S Bini, A Clavenna, A E Rigamonti, et al.
Neurochemistry International
|
July 1, 1994
Neuroendocrine aging: its impact on somatotrophic function
V De Gennaro Colonna, S G Cella, M Parenti, et al.
Journal of Endocrinological Investigation
|
June 1, 1984
Growth-hormone releasing factor and clonidine in children with constitutional growth delay. Evidence for defective pituitary growth hormone reserve
C Pintor, R Puggioni, V Fanni, et al.
Thrombosis Research
|
March 1, 1983
Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders
G Cella, S I Colby, A D Taylor, et al.
Trends in Endocrinology and Metabolism: TEM
|
April 30, 2005
Growth hormone abuse: methods of detection
Antonello E Rigamonti, Silvano G Cella, Nicoletta Marazzi, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?
Antonello E Rigamonti, Michele Dei Cas, Diana Caroli, et al.
Page
of 31
Search research articles
Search
Showing results (171-180 of 310) with videos related to
Sort By:
Page
of 31
Seminars in Thrombosis and Hemostasis
|
November 5, 1999
Preclinical differentiation of low molecular weight heparins
H B Nader, J M Walenga, S D Berkowitz, et al.
Drugs
|
February 1, 1991
Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications
E E Müller, V Locatelli, E Ghigo, et al.
Clinical Endocrinology
|
August 1, 1986
The effect of oxandrolone on the growth hormone response to growth hormone releasing hormone in children with constitutional growth delay
S Loche, R Corda, A Lampis, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1997
Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration
G Cella, A Cipriani, A Tommasini, et al.
Journal of Immigrant and Minority Health
|
July 28, 2016
Drugs Delivery by Charities: A Possible Epidemiologic Indicator in Children of Undocumented Migrants
S Bini, A Clavenna, A E Rigamonti, et al.
Neurochemistry International
|
July 1, 1994
Neuroendocrine aging: its impact on somatotrophic function
V De Gennaro Colonna, S G Cella, M Parenti, et al.
Journal of Endocrinological Investigation
|
June 1, 1984
Growth-hormone releasing factor and clonidine in children with constitutional growth delay. Evidence for defective pituitary growth hormone reserve
C Pintor, R Puggioni, V Fanni, et al.
Thrombosis Research
|
March 1, 1983
Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders
G Cella, S I Colby, A D Taylor, et al.
Trends in Endocrinology and Metabolism: TEM
|
April 30, 2005
Growth hormone abuse: methods of detection
Antonello E Rigamonti, Silvano G Cella, Nicoletta Marazzi, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?
Antonello E Rigamonti, Michele Dei Cas, Diana Caroli, et al.
Page
of 31